Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Net Cash Flow: 2017-2021

Historic Net Cash Flow for Cogent Biosciences (COGT) over the last 5 years, with Dec 2021 value amounting to $16.8 million.

  • Cogent Biosciences' Net Cash Flow fell 85.11% to $16.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$22.4 million, marking a year-over-year decrease of 111.40%. This contributed to the annual value of $44.9 million for FY2024, which is 151.11% up from last year.
  • Per Cogent Biosciences' latest filing, its Net Cash Flow stood at $16.8 million for Q4 2021, which was up 210.38% from -$15.2 million recorded in Q3 2021.
  • In the past 5 years, Cogent Biosciences' Net Cash Flow ranged from a high of $112.8 million in Q4 2020 and a low of -$15.2 million during Q3 2021.
  • Moreover, its 3-year median value for Net Cash Flow was -$8.0 million (2020), whereas its average is $13.0 million.
  • As far as peak fluctuations go, Cogent Biosciences' Net Cash Flow plummeted by 497.02% in 2019, and later skyrocketed by 1,433.29% in 2020.
  • Cogent Biosciences' Net Cash Flow (Quarterly) stood at -$2.4 million in 2017, then surged by 371.28% to $6.4 million in 2018, then slumped by 232.67% to -$8.5 million in 2019, then spiked by 1,433.29% to $112.8 million in 2020, then plummeted by 85.11% to $16.8 million in 2021.
  • Its Net Cash Flow stands at $16.8 million for Q4 2021, versus -$15.2 million for Q3 2021 and -$12.5 million for Q2 2021.